Who can pay for innovative medicines?

European Respiratory Journal

Volumn 41, Issue 3, 2013, Pages 495-496

  Decramer, Stefaan ^a   Decramer, Marc ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; NEW DRUG;

COST CONTROL; DRUG APPROVAL; DRUG COST; DRUG INDUSTRY; DRUG RESEARCH; EDITORIAL; EUROPEAN UNION; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH CARE SYSTEM; PATENT; PRIORITY JOURNAL; REIMBURSEMENT; UNITED STATES;

BIOMEDICAL RESEARCH; DRUG DISCOVERY; DRUG INDUSTRY; DRUG THERAPY; ECONOMICS, PHARMACEUTICAL; EUROPE; FINANCING, GOVERNMENT; HUMANS; RESPIRATORY TRACT DISEASES; UNITED STATES;

EID: 84875249913     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00135412     Document Type: Editorial

References (12)

1. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the noncommunicable disease crisis. Lancet 2011; 377: 1438-1447.
2. Beaglehole R, Bonita R, Alleyne G, et al. UN high-level meeting on non-communicable diseases questions. Lancet 2011; 378: 449-455.
3. The Lancet. Where will new drugs come from?Lancet 2011; 377: 97.
4. Paul SM, Mytelka DS, Dunwiddie CT, et al. How to improve R&D productivity: The pharmaceutical industry's grand challenge. Nature Reviews 2010; 9: 203-214.
5. Decramer M, Sibille Y, eds. European Respiratory Roadmap. Lausanne, European Respiratory Society, 2011. Available from: Www.ersroadmap.org
6. IMAP: Pharmaceuticals and Biotech Industry Global Report 2011. IMAP, 2011. Available from: Www.imap.com
7. Kamel N, Compton C, Middelveld R, et al. The Innovative Medicines Initiative (IMI): A new opportunity for scientific collaboration between academia and industry at the European level. Eur Respir J 2008; 31: 924-926.
8. Stevens AJ, Jensen JJ, Wyller K, et al. The role of public-sector research in the discovery of drugs and vaccines. N Eng J Med 2011; 364: 535-541.
9. Behnke N, Hueltenschmidt N. Changing Pharma's Innovation DNA. Boston, Bain and Company, 2010.
10. Pharmaceutical Research and Manufacturers of America: Pharmaceutical Industry Profile 2012. Washington, PhRMA, 2012. Available from: Www.phrma.org
11. Bristol N. NIH proposes new drug development center. Lancet 2011; 377: 705-706.
12. Kanavos P, Vandoros S, Irwin R, et al. Differences in Costs of and Access to Pharmaceutical Products in the EU 2011. Brussels, European Parliament, 2011. Available from: Www.europarl.europa. eu/activities/committees/studies.do? language5EN